Biogen Earnings, Revenue Beat in Q1
Investing.com - Biogen (NASDAQ:BIIB) reported first quarter earnings that Beat analysts' expectations on Wednesday and revenue that topped forecasts.
The firm reported earnings per share of $6.98 on revenue of $3.49B. Analysts polled by Investing.com anticipated EPS of $6.83 on revenue of $3.38B. That compared to EPS of $6.05 on revenue of $3.13B in the same period a year earlier. The company had reported EPS of $6.99 on revenue of $3.53B in the previous quarter.
Biogen follows other major Healthcare sector earnings this month
On April 16, J&J reported first quarter EPS of $2.1 on revenue of $20.02B, compared to forecasts of EPS of $2.04 on revenue of $19.61B.
Novartis ADR earnings Beat analysts' expectations on Wednesday, with first quarter EPS of $1.21 on revenue of $11.11B. Investing.com analysts expected EPS of $1.1 on revenue of $11.4B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar
Related Articles
Biogen first-quarter profit rises 20 percent on Spinraza strength
